Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Operating Leases (2019 - 2025)

Rockwell Medical (RMTI) has disclosed Operating Leases for 7 consecutive years, with $1.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Leases fell 17.83% year-over-year to $1.7 million, compared with a TTM value of $1.7 million through Sep 2025, down 17.83%, and an annual FY2024 reading of $1.7 million, up 18.56% over the prior year.
  • Operating Leases was $1.7 million for Q3 2025 at Rockwell Medical, down from $2.0 million in the prior quarter.
  • Across five years, Operating Leases topped out at $6.9 million in Q2 2022 and bottomed at $1.4 million in Q4 2023.
  • Average Operating Leases over 5 years is $3.4 million, with a median of $2.6 million recorded in 2022.
  • The sharpest move saw Operating Leases surged 223.28% in 2021, then crashed 67.59% in 2023.
  • Year by year, Operating Leases stood at $5.9 million in 2021, then tumbled by 56.16% to $2.6 million in 2022, then crashed by 44.48% to $1.4 million in 2023, then grew by 18.56% to $1.7 million in 2024, then grew by 1.47% to $1.7 million in 2025.
  • Business Quant data shows Operating Leases for RMTI at $1.7 million in Q3 2025, $2.0 million in Q2 2025, and $2.9 million in Q1 2025.